Jennifer A. Kanakry

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Marić, Steven D. Hartman et al. · Journal of Clinical Oncology · 2018 · 791 citations · Full text

Medicine, Hematology, Immunology +15

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel et al. · Blood · 2015 · 300 citations · Full text

Medicine, Hematology, Immunology +14

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince et al. · Journal of Clinical Oncology · 2015 · 239 citations

Medicine, Hematology, Immunology +17

The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases

Jennifer A. Kanakry, Aparna Hegde, Christine M. Durand et al. · Blood · 2016 · 229 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños‐Meade et al. · Blood · 2014 · 198 citations · Full text

Medicine, Hematology, Pharmacotherapy +16